Isto Biologics is an orthobiologics company that develops spine and orthopedic solutions.
Here are six things to know:
1. The company's novel biosynthetic bone graft extender and substitute InQu are designed to promote bone formation in orthopedic procedures and spinal fusions.
2. Study results published in Frontiers in Surgery demonstrated that InQu supports significantly faster spinal fusion compared to beta-tricalcium phosphate and is associated with higher overall fusion rates at 12-months.
3. The company's Influx trabecular bone graft is a natural material designed to provide osteoinductivity and promote cell ingrowth.
4. Isto Biologics also manufactures the Magellan autologous platelet separator, Lightning aspiration needle and CellPoint concentrate bone marrow aspirate system.
5. The company provides blood management services.
6. In 2017, Isto Biologics acquired Progenicare, a medical sales and service company.